Found 29 matching trials
Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
NALevodopa-Carbidopa intestinal gel (LCIG) is an effective therapy for compli...
Location
University Hospital of Ferrara - Arcispedale Sant'Anna
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
PHASE3The primary objective of this study is to provide continued access to levod...
Location
University of Alabama at Birmingham /ID# 49941
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
PHASE4An open, observational health economic study to estimate marginal cost and ...
Location
Akershus University Hospital
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
PHASE3The primary objective of this study was to demonstrate the superiority of l...
Location
Site Reference ID/Investigator# 45719
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
N/AThe purpose of this study is to assess the safety and efficacy of long-term...
Location
Nagoya University Hospital /ID# 212303
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
PHASE4The primary objective of this study is to collect health economic data depi...
Location
Multiple Locations
Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease
NATo evaluate the role of dietary modifications of 3 different diets on clini...
Location
Multiple Locations
Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease
PHASE1In patients with Parkinson's disease, the characteristic motor symptoms, i....
Location
Sahlgrenska Universtiy Hospital, Dep of Neurology
Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
N/APatient reported outcomes (PRO) have become an important endpoint assessed ...
Location
Multiple Locations
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
PHASE3Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal ...
Location
Site Reference ID/Investigator# 45869